Ginsenoside Rd
- CAS No.
- 52705-93-8
- Chemical Name:
- Ginsenoside Rd
- Synonyms
- Chikusetsusaponin FK7;Gypenoside VIII;ginsenosideR;Panaxoside Rd;GINSENOSIDE RD;GINSENOOSIDERD;Sanchinoside Rd;Rd Ginsenoside Rd;Ginsenoside Rd-RM;Ginsenoside Rd(AS)
- CBNumber:
- CB1281187
- Molecular Formula:
- C48H82O18
- Molecular Weight:
- 947.15
- MDL Number:
- MFCD00799993
- MOL File:
- 52705-93-8.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| Product description | Number | Pack Size | Price |
| Ginsenoside Rd ≥98% (HPLC) | SML4126 | 10 mg | $106 |
| Ginsenoside Rd ≥98% (HPLC) | SML4126 | 50 mg | $320 |
| Ginsenoside Rd phyproof? Reference Substance | PHL89211 | 10MG | $232 |
| Ginsenoside Rd analytical standard | 01518 | 10mg | $317 |
| Ginsenoside Rd ≥98% (HPLC) | SML4126 | 1 unit | $94.05 |
| More product size | |||
| Melting point | 204~206℃ |
|---|---|
| Boiling point | 1015.6±65.0 °C(Predicted) |
| Density | 1.38±0.1 g/cm3(Predicted) |
| storage temp. | Inert atmosphere,2-8°C |
| solubility | DMSO (Slightly), Methanol (Slightly) |
| pka | 12.85±0.70(Predicted) |
| form | Solid |
| color | White to Off-White |
| Stability | Hygroscopic |
| Cosmetics Ingredients Functions | ANTIOXIDANT |
| InChIKey | FBFMBWCLBGQEBU-FIKSETHBNA-N |
| LogP | 3.110 (est) |
| CAS DataBase Reference | 52705-93-8(CAS DataBase Reference) |
| FDA UNII | WB232T95AV |
| UNSPSC Code | 85151701 |
| NACRES | NA.24 |
Ginsenoside Rd price More Price(47)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | SML4126 | Ginsenoside Rd ≥98% (HPLC) | 52705-93-8 | 10 mg | $106 | 2026-04-30 | Buy |
| Sigma-Aldrich | SML4126 | Ginsenoside Rd ≥98% (HPLC) | 52705-93-8 | 50 mg | $320 | 2026-04-30 | Buy |
| Sigma-Aldrich | PHL89211 | Ginsenoside Rd phyproof? Reference Substance | 52705-93-8 | 10MG | $232 | 2026-04-30 | Buy |
| Sigma-Aldrich | 01518 | Ginsenoside Rd analytical standard | 52705-93-8 | 10mg | $317 | 2026-04-30 | Buy |
| Sigma-Aldrich | SML4126 | Ginsenoside Rd ≥98% (HPLC) | 52705-93-8 | 1 unit | $94.05 | 2025-07-31 | Buy |
Ginsenoside Rd Chemical Properties,Uses,Production
Description
Ginsenosides are pharmacologically active natural constituents of ginseng and other plants of the genus Panax. Structurally, they are steroid glycosides derived from the triterpene squalene. Ginsenoside Rd is a protopanaxadiol which is more abundant in some Panax species (e.g., P. quinquefolium) than others. This ginsenoside has diverse in vitro and in vivo effects, including cardioprotective, neuroprotective, and anti-
Chemical Properties
White to off-white crystals powder
Uses
Ginsenoside RD has been shown to attenuate tau protein phosphorylation via the PI3K/AKT/GSK-3β pathway after forebrain ischemia. This could be used to counter the risk of developing post-stroke dementia.
Definition
ChEBI: Ginsenoside Rd is a ginsenoside found in Panax ginseng and Panax japonicus var. major that is (20S)-ginsenoside Rg3 in which the hydroxy group at position 20 has been converted to its beta-D-glucopyranoside. It has a role as a vulnerary, a neuroprotective agent, an apoptosis inducer, an anti-inflammatory drug, an immunosuppressive agent and a plant metabolite. It is a ginsenoside, a beta-D-glucoside and a tetracyclic triterpenoid. It is functionally related to a (20S)-ginsenoside Rg3.
in vivo
Ginsenosides Rd is a major compound isolated from Gynostemma pentaphyllum that holistically improves gut microenvironment and induces anti-polyposis in ApcMin/+ mice. Six-weeks-old mice are subjected to Ginsenoside Rd treatment, before the appearance of the intestinal polyps. All the mice are monitored for food intake, water consumption, and weight changes. Throughout the experiment, no Rb3/ Ginsenoside Rd-associated weight loss in mice is observed. In addition, none of the treated mice show variations in food and water consumption. Whereas, the number and size of the polyps are effectively reduced by Ginsenoside Rd treatments[3].
IC 50
NF-κB: 12.05 μM (IC50, in HepG2 cells); COX-2; L-type calcium channel; CYP2D6: 58 μM (IC50); CYP1A2: 78.4 μM (IC50); CYP3A4: 81.7 μM (IC50); CYP2C9: 85.1 μM (IC50)
References
[1] CHIEH-FU CHEN Jun tian Z Wen fei Chiou. Comparison of the pharmacological effects of Panax ginseng and Panax quinquefolium[J]. Acta Pharmacologica Sinica, 2008, 29 9: 1103-1108. DOI: 10.1111/j.1745-7254.2008.00868.x
[2] YANG WANG. Ginsenoside Rd attenuates myocardial ischemia/reperfusion injury via Akt/GSK-3β signaling and inhibition of the mitochondria-dependent apoptotic pathway.[J]. PLoS ONE, 2013: e70956. DOI: 10.1371/journal.pone.0070956
[3] X. LIU. Ginsenoside-Rd improves outcome of acute ischaemic stroke – a randomized, double-blind, placebo-controlled, multicenter trial[J]. European Journal of Neurology, 2012, 19 6: 855-863. DOI: 10.1111/j.1468-1331.2011.03634.x
[4] SEOK BEAN SONG. Inhibition of TNF-α-mediated NF-κB Transcriptional Activity in HepG2 Cells by Dammarane-type Saponins from Panax ginseng Leaves.[J]. Journal of Ginseng Research, 2012, 36 2: 146-152. DOI: 10.5142/jgr.2012.36.2.146
Ginsenoside Rd Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Shaanxi Cuikang Pharmaceutical Technology Co., Ltd | +8618791163155 | 18791163155@163.com | China | 3397 | 58 |
| Shaanxi Xianhe Biotech Co., Ltd | +86-17709210191; +8617709210191 | Jerry@xhobio.com | China | 906 | 58 |
| Capot Chemical Co.,Ltd. | +86-(0)57185586718; +8613336195806 | sales@capot.com | China | 29640 | 60 |
| Shanghai Zheyan Biotech Co., Ltd. | 18017610038 | zheyansh@163.com | CHINA | 3619 | 58 |
| career henan chemical co | +86-0371-86658258 +8613203830695 | sales@coreychem.com | China | 29819 | 58 |
| Chengdu Biopurify Phytochemicals Ltd. | +86-28-82633860; +8618080483897 | sales@biopurify.com | China | 3751 | 58 |
| Shaanxi Pioneer Biotech Co., Ltd . | +8613259417953 | sales@pioneerbiotech.com | China | 1287 | 58 |
| NanJing Spring & Autumn Biological Engineering CO., LTD. | +8613815430202 | sale02@cqherb.com | CHINA | 376 | 58 |
| BOC Sciences | +1-631-485-4226 | inquiry@bocsci.com | United States | 19552 | 58 |
| Shanghai Standard Technology Co., Ltd. | 18502101150 | ft-sales@nature-standard.com | CHINA | 1923 | 58 |
Related articles
- The Role of Ginsenoside Rd in Neurological Diseases
- Ginsenoside Rd crosses the blood-brain barrier and exerts neuroprotective effects via anti-inflammatory, anti-apoptotic pathwa....
- Feb 12,2026
View Lastest Price from Ginsenoside Rd manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-04-30 | GINSENOSIDE Rd
52705-93-8
|
US $0.00 / kg | 1kg | 0.99 | 1000kg | Shaanxi Xianhe Biotech Co., Ltd | |
![]() |
2026-04-22 | Ginsenoside Rd
52705-93-8
|
US $33.00-106.00 / mg | 99.50% | 10g | TargetMol Chemicals Inc. | ||
![]() |
2023-02-24 | Ginsenoside Rd
52705-93-8
|
US $0.00 / mg | 5mg | ≥98%(HPLC) | 10 g | Shanghai Standard Technology Co., Ltd. |
-

- GINSENOSIDE Rd
52705-93-8
- US $0.00 / kg
- 0.99
- Shaanxi Xianhe Biotech Co., Ltd
-

- Ginsenoside Rd
52705-93-8
- US $33.00-106.00 / mg
- 99.50%
- TargetMol Chemicals Inc.
-

- Ginsenoside Rd
52705-93-8
- US $0.00 / mg
- ≥98%(HPLC)
- Shanghai Standard Technology Co., Ltd.





